Skip to main content
Caplight Logo









STAQ Pharma

STAQ Pharma

Private
Denver, ColoradoHealthcare & Life Scienceshttps://staqpharma.com/

Last Round

Grant

Apr 22, 2025

Est. Valuation

$183M

Total Funding Raised

$87.06M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

STAQ Pharma is a pharmaceutical company that operates as an FDA-registered 503B outsourcing facility providing sterile, ready-to-use injectable medications to hospitals and healthcare systems.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Compliance

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

503B outsourcingsterile compoundingsterile injectable medicationsdrug shortage solutionshospital pharmacy supplycompounded sterile preparationsready-to-administer medicationsFDA-registered facilitypharmaceutical manufacturingpharmacy outsourcinghospital supply chainbatch productionsterile manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

STAQ Pharma Comparables

Compare STAQ Pharma with similar companies based on industry and business-model similarity.

STAQ Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Leiters Health
91%
SCA Pharma
87%
Medivant Healthcare
87%

STAQ Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 22, 2025
Series DSep 1, 2024
Series DJun 20, 2023
Series CMar 2, 2022
Series BMar 31, 2021
Debt
Jan 5, 2021

Key People

Founding team and executive leadership

David Colson

Chief Financial Officer

Executive Team

STAQ Pharma Investors

Notable investors and investment history

STAQ Pharma investors
InvestorRounds
University Hospitals VenturesSeries C
Angels for ChangeGrant
Rev1 VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 13, 2026

    Monthly visitors increased 47% MoM.

  • Apr 22, 2025

    Received grant funding to support operations.

STAQ Pharma Filings

Explore SEC and related filing metadata, where available.

STAQ Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about STAQ Pharma's valuation, stock price, and market status.

Is STAQ Pharma a public or private company?

STAQ Pharma is a private company.

What is the current stock price of STAQ Pharma?

STAQ Pharma is a private company, so its shares have no public market price. Caplight tracks STAQ Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is STAQ Pharma worth (valuation)?

STAQ Pharma's valuation is estimated at $183.0M based on funding round data.

Can I buy STAQ Pharma stock?

STAQ Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was STAQ Pharma's last funding round?

STAQ Pharma's most recent funding round was Grant on April 22, 2025.

Who are the main investors in STAQ Pharma?

Key investors in STAQ Pharma include University Hospitals Ventures.

Will STAQ Pharma IPO soon?

No public IPO plans have been announced for STAQ Pharma.

How can I track STAQ Pharma secondary market activity?

Caplight tracks bids, offers, and trades in STAQ Pharma's shares on secondary markets.

Firmographic Details

HeadquartersDenver, Colorado
Employee Range123
Year Founded2018
Last FundingApr 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?